{
     "PMID": "25796435",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20160120",
     "LR": "20150502",
     "IS": "1872-6240 (Electronic) 0006-8993 (Linking)",
     "VI": "1609",
     "DP": "2015 Jun 3",
     "TI": "Effect of acute NR2B antagonist treatment on long-term potentiation in the rat hippocampus.",
     "PG": "31-9",
     "LID": "10.1016/j.brainres.2015.03.019 [doi] S0006-8993(15)00201-2 [pii]",
     "AB": "The long lasting antidepressant response seen following acute, i.v. ketamine administration in patients with treatment-resistant depression (TRD) is thought to result from enhanced synaptic plasticity in cortical and hippocampal circuits. Using extracellular field recordings in rat hippocampal slices, we show that a single dose of the non-selective NMDA receptor antagonist ketamine or CP-101,606, a selective antagonist of the NR2B subunit of the NMDA receptor, enhances hippocampal synaptic plasticity induced with high frequency stimulation (HFS) 24h after dosing - a time at which plasma concentrations of the drug are no longer detectable in the animal. These results indicate that acute inhibition of NMDA receptors containing the NR2B subunit can lead to long-lasting changes in hippocampal plasticity.",
     "CI": [
          "Copyright (c) 2015 Elsevier B.V. All rights reserved."
     ],
     "FAU": [
          "Graef, John D",
          "Newberry, Kimberly",
          "Newton, Amy",
          "Pieschl, Rick",
          "Shields, Eric",
          "Luan, Fu-Ni",
          "Simmermacher, Jean",
          "Luchetti, David",
          "Schaeffer, Eric",
          "Li, Yu-Wen",
          "Kiss, Laszlo",
          "Bristow, Linda J"
     ],
     "AU": [
          "Graef JD",
          "Newberry K",
          "Newton A",
          "Pieschl R",
          "Shields E",
          "Luan FN",
          "Simmermacher J",
          "Luchetti D",
          "Schaeffer E",
          "Li YW",
          "Kiss L",
          "Bristow LJ"
     ],
     "AD": "Neuroscience Biology, Bristol-Myers Squibb Company, Wallingford, CT, USA. Electronic address: john.graef@bms.com. Neuroscience Biology, Bristol-Myers Squibb Company, Wallingford, CT, USA. Neuroscience Biology, Bristol-Myers Squibb Company, Wallingford, CT, USA. Neuroscience Biology, Bristol-Myers Squibb Company, Wallingford, CT, USA. Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Company, Wallingford, CT, USA. Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Company, Wallingford, CT, USA. Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Company, Wallingford, CT, USA. Neuroscience Clinical Biomarkers, Bristol-Myers Squibb Company, Wallingford, CT, USA. Neuroscience Clinical Biomarkers, Bristol-Myers Squibb Company, Wallingford, CT, USA. Neuroscience Biology, Bristol-Myers Squibb Company, Wallingford, CT, USA. Neuroscience Biology, Bristol-Myers Squibb Company, Wallingford, CT, USA. Neuroscience Biology, Bristol-Myers Squibb Company, Wallingford, CT, USA.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20150319",
     "PL": "Netherlands",
     "TA": "Brain Res",
     "JT": "Brain research",
     "JID": "0045503",
     "RN": [
          "0 (Antidepressive Agents)",
          "0 (Excitatory Amino Acid Antagonists)",
          "0 (NR2B NMDA receptor)",
          "0 (Piperidines)",
          "0 (Receptors, N-Methyl-D-Aspartate)",
          "690G0D6V8H (Ketamine)",
          "BD2A56I30W (traxoprodil mesylate)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Antidepressive Agents/pharmacokinetics/pharmacology",
          "Electric Stimulation/methods",
          "Excitatory Amino Acid Antagonists/pharmacokinetics/*pharmacology",
          "Hippocampus/*drug effects/physiology",
          "Ketamine/*pharmacology",
          "Long-Term Potentiation/*drug effects/physiology",
          "Male",
          "Piperidines/pharmacokinetics/*pharmacology",
          "Rats, Sprague-Dawley",
          "Receptors, N-Methyl-D-Aspartate/*antagonists & inhibitors/metabolism",
          "Time Factors",
          "Tissue Culture Techniques"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Ex vivo",
          "Hippocampus",
          "Long-term potentiation",
          "NMDA receptors",
          "NR2B subunit",
          "Plasticity",
          "Treatment-resistant depression"
     ],
     "EDAT": "2015/03/23 06:00",
     "MHDA": "2016/01/21 06:00",
     "CRDT": [
          "2015/03/23 06:00"
     ],
     "PHST": [
          "2014/12/04 00:00 [received]",
          "2015/03/05 00:00 [revised]",
          "2015/03/10 00:00 [accepted]",
          "2015/03/23 06:00 [entrez]",
          "2015/03/23 06:00 [pubmed]",
          "2016/01/21 06:00 [medline]"
     ],
     "AID": [
          "S0006-8993(15)00201-2 [pii]",
          "10.1016/j.brainres.2015.03.019 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Brain Res. 2015 Jun 3;1609:31-9. doi: 10.1016/j.brainres.2015.03.019. Epub 2015 Mar 19.",
     "term": "hippocampus"
}